Lipid Panel Interpretation
Your lipid panel shows significantly elevated LDL cholesterol at 4.33 mmol/L (167 mg/dL), borderline low HDL cholesterol at 1.17 mmol/L (45 mg/dL), and reassuringly low lipoprotein(a) at <10 mg/dL—this profile indicates increased cardiovascular risk requiring intervention.
What These Numbers Mean
LDL Cholesterol: 4.33 mmol/L (167 mg/dL) - ELEVATED
Your LDL cholesterol is substantially above target levels. According to current guidelines:
- Target LDL for most adults should be <2.6 mmol/L (100 mg/dL) 1, 2
- For very high-risk individuals (those with established cardiovascular disease or diabetes), the target is even lower at <1.8 mmol/L (70 mg/dL) 1
- Your level of 4.33 mmol/L places you at significantly increased cardiovascular risk
The clinical significance: Every 1% increase in LDL cholesterol is associated with slightly more than a 2% increase in coronary artery disease risk over 6 years 3. At your current level, you are well above the threshold where pharmacological therapy (statin medication) should be considered alongside lifestyle modifications 4, 1.
HDL Cholesterol: 1.17 mmol/L (45 mg/dL) - BORDERLINE LOW
Your HDL cholesterol is just above the minimum threshold but not optimal:
- Target HDL should be >1.0 mmol/L (40 mg/dL) for men and >1.2 mmol/L (45-50 mg/dL) for women 4, 5, 6
- HDL cholesterol <1.0 mmol/L (40 mg/dL) in men and <1.2 mmol/L (45 mg/dL) in women is considered a marker of increased cardiovascular risk 6
The clinical significance: Every 1% decrease in HDL is associated with a 3-4% increase in coronary artery disease risk 3. Low HDL is an independent risk factor that can rival high LDL cholesterol in predicting heart disease 6. Your borderline level suggests room for improvement through lifestyle modifications.
Lipoprotein(a): <10 mg/dL - FAVORABLE
This is the one positive finding in your lipid panel:
- Elevated Lp(a) is generally defined as >50 mg/dL (≈125 nmol/L) 1, 7
- Your level of <10 mg/dL is well within the favorable range
- The 2026 guidelines recommend measuring Lp(a) at least once in a lifetime for risk assessment 8, 9
The clinical significance: Elevated Lp(a) is an independent risk factor for cardiovascular disease that adds to LDL-mediated risk 7, 10. Your low Lp(a) means you do NOT have this additional genetic risk factor, which is reassuring. However, this does not offset your elevated LDL cholesterol risk 7.
Your Cardiovascular Risk Status
Based on your lipid profile alone, you fall into a category requiring intervention:
- Your LDL of 167 mg/dL exceeds the threshold (130 mg/dL) where drug therapy should be considered 4, 11, 2
- If you have additional risk factors (age >40-45 for men/>55 for women, smoking, hypertension, family history of premature heart disease, or diabetes), you are at even higher risk and require more aggressive treatment 5, 2
Recommended Actions
Immediate Steps:
Lifestyle modifications (should begin immediately):
Statin therapy should be strongly considered, particularly if:
Target goals with treatment:
Follow-up:
- Lipid panel should be rechecked annually, or more frequently if treatment is initiated 4, 11
- If lifestyle modifications alone are attempted, reassess in 3-6 months 11
- However, given your LDL level of 167 mg/dL, waiting 3-6 months for lifestyle changes alone is not recommended—pharmacological therapy should be initiated concurrently 4
Critical Context
Your low Lp(a) is favorable, but it does not eliminate your cardiovascular risk from elevated LDL cholesterol. Recent evidence demonstrates that LDL-C and Lp(a) contribute independently and additively to cardiovascular risk 7. Even with optimal Lp(a) levels, your elevated LDL requires treatment to reduce your risk of heart attack, stroke, and other cardiovascular events.